Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:angiotensin II receptor antagonist
go back to main search page
Accession:XCO:0000536 term browser browse the term
Definition:This is any condition in which the main influencing factor is an angiotensin II receptor antagonist, an agent that blocks angiotensin II receptors and is used to treat high blood pressure and heart failure.
Synonyms:exact_synonym: ARB;   angiotensin II receptor blocker;   angiotensin receptor blocker;   sartan


show annotations for term's descendants           Sort by:
losartan term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Bp251 Blood pressure QTL 251 IDA RGD PMID:12545249 RGD:1303389 NCBI chr 3:14,489,145...121,056,321 JBrowse link
Q Bp254 Blood pressure QTL 254 IDA RGD PMID:12545249 RGD:1303389 NCBI chr 5:58,829,236...128,034,027 JBrowse link
Q Bp255 Blood pressure QTL 255 IDA RGD PMID:12545249 RGD:1303389 NCBI chr 1:191,019,702...246,062,233 JBrowse link
Q Bp259 Blood pressure QTL 259 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 1:210,702,053...260,522,016 JBrowse link
Q Bp260 Blood pressure QTL 260 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 1:151,162,766...225,824,951 JBrowse link
Q Bp261 Blood pressure QTL 261 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 5:90,067,849...128,034,027 JBrowse link
Q Bp262 Blood pressure QTL 262 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 8:27,205,715...99,103,503 JBrowse link
Q Bp263 Blood pressure QTL 263 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 8:93,965,141...123,900,184 JBrowse link
Q Bp264 Blood pressure QTL 264 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 3:14,489,145...121,056,321 JBrowse link
Q Bp265 Blood pressure QTL 265 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 7:83,591,953...134,666,232 JBrowse link
Q Bp266 Blood pressure QTL 266 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 7:83,591,953...134,666,232 JBrowse link
Q Bw47 Body weight QTL 47 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 1:90,508,614...180,359,386 JBrowse link
Q Bw48 Body weight QTL 48 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:157,142,078...211,086,598 JBrowse link
Q Bw49 Body weight QTL 49 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,652...157,142,078 JBrowse link
Q Bw50 Body weight QTL 50 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,652...157,142,078 JBrowse link
Q Bw51 Body weight QTL 51 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 8:51,351,728...107,062,046 JBrowse link
Q Cm38 Cardiac mass QTL 38 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...157,142,209 JBrowse link
Q Cm39 Cardiac mass QTL 39 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...157,142,209 JBrowse link
Q Cm40 Cardiac mass QTL 40 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 8:27,205,715...99,103,503 JBrowse link
Q Cm41 Cardiac mass QTL 41 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...203,928,301 JBrowse link
Q Cm42 Cardiac mass QTL 42 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...203,928,301 JBrowse link
Q Kidm22 Kidney mass QTL 22 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 1:210,702,053...240,947,965 JBrowse link
Q Kidm23 Kidney mass QTL 23 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...157,142,209 JBrowse link
Q Kidm24 Kidney mass QTL 24 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...157,142,209 JBrowse link
Q Kidm25 Kidney mass QTL 25 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 5:90,067,849...128,034,027 JBrowse link
Q Kidm26 Kidney mass QTL 26 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 8:27,205,715...99,103,503 JBrowse link
Q Kidm27 Kidney mass QTL 27 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...157,142,209 JBrowse link
Q Kidm28 Kidney mass QTL 28 IDA RGD PMID:14640890 RGD:1303386 NCBI chr 2:25,413,423...157,142,209 JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    therapeutic agent 101
      antihypertensive agent 29
        angiotensin II receptor antagonist 28
          E4177 + 0
          allisartan 0
          candesartan + 0
          eprosartan 0
          losartan + 28
          olmesartan medoxomil 0
          saralasin 0
          telmisartan 0
          valsartan 0
Path 2
Term Annotations click to browse term
  experimental condition 2376
    chemical 1266
      chemical with specified function 517
        inhibitor 40
          receptor antagonist 31
            angiotensin II receptor antagonist 28
              E4177 + 0
              allisartan 0
              candesartan + 0
              eprosartan 0
              losartan + 28
              olmesartan medoxomil 0
              saralasin 0
              telmisartan 0
              valsartan 0
paths to the root